Sequent Scientific receives WHO approval for its Vizag facility

Sequent Scientific announced receipt of WHO - GENEVA approval for API Praziquantel (Anthelmintic) under pre-qualification program. Alivira's Vizag site is India's only US FDA-authorized and EU GMP-compliant facility focused on production of active pharmaceutical ingredients (APIs) for the animal health sector.

The Vizag site is a multipurpose manufacturing facility equipped with reactor capacity of 225KL and six clean rooms. The site began commercial production in 2015 and has been successfully inspected by USFDA during 2016 and 2018.

This approval further emphasizes our focus on compliance standards.

Powered by Capital Market - Live News